ONCTERNAL THERAPEUTICS INC (ONCT)

US68236P1075 - Common Stock

0.296  -0.01 (-4.52%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to ONCT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.94. This target is 554.73% above the current price.
ONCT was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about ONCT.
In the previous month the buy percentage consensus was at a similar level.
ONCT was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 0.301.311.941.942.63 - 343.58% 554.73% 554.73% 786.82%
Up and Down Grades
Date Firm Action Rating
2023-09-18 HC Wainwright & Co. Upgrade Neutral -> Buy
2023-09-07 Cantor Fitzgerald Reiterate Neutral -> Neutral
2023-06-06 HC Wainwright & Co. Reiterate Neutral
2023-04-04 Cantor Fitzgerald Maintains Overweight
2023-04-04 Brookline Capital Downgrade Buy -> Hold
2023-04-04 Oppenheimer Downgrade Outperform -> Perform
2023-04-04 Maxim Group Downgrade Buy -> Hold
2023-04-04 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-03-22 Oppenheimer Maintains Outperform
2023-03-14 HC Wainwright & Co. Reiterate Buy
2022-12-22 Cantor Fitzgerald Initiate Overweight
2022-08-10 HC Wainwright & Co. Maintains Buy
2022-05-10 Maxim Group Initiate Buy
2022-02-24 BTIG Initiate Buy
2021-04-07 Oppenheimer Initiate Outperform
2021-03-30 Brookline Capital Initiate Buy
2021-03-12 HC Wainwright & Co. Maintains Buy